JOSEPH SHARKEY: Open Payments
NPI 1649277435 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 36 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $16 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Amgen Inc. | 5 | $91 |
| ABBVIE INC. | 3 | $86 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| PFIZER INC. | 3 | $66 |
| Exact Sciences Corporation | 3 | $63 |
| Lilly USA, LLC | 2 | $40 |
| Alkermes, Inc. | 1 | $30 |
| ViiV Healthcare Company | 1 | $28 |
Products named: REXULTI, VRAYLAR, PREVNAR 20, AIRSUPRA, OTEZLA, MOUNJARO, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across CO — which companies pay providers there.
